Biopharmaceutical company developing enabling technology platforms and enhanced natural therapeutics for certain infectious diseases, cancers and CNS disorders
Enhanced therapeutics include small molecules from medicinal plants and marine organisms, and improved drug delivery formulations of protein macromolecules and hydrophobic anticancer drugs
Enabling technology platforms, nanotechnologies and therapeutic products covered by 33 issued U.S. and international patents, and 27 pending patent applications
History of collaborations with multinational companies such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, and leading academic institutions.
This product profile describes the features and applications of the ElectroGreen™–Xylene substitute for electronics.
The Stäubli Megawatt Charging System (MCS) offers rapid and effortless charging, allowing drivers to manually charge their electric heavy-duty vehicles without relying on robots or supporting machines.
Anguil's robust Vapor Combustion Unit (VCU) can handle a wide range of emission flow rates. It is as easy to use as an enclosed flare and as effective as a thermal oxidizer.
In this interview, AZoCleantech speaks with Imperial College London graduate Felix Chen about ALGAEWAVE, a closed-loop autonomous microalgae farming system that uses noise treatment to optimize biomass production.
This interview with Jeff Retzke examines how Denali is revitalizing mine sites and restoring ecosystems through innovative reclamation practices.
In this interview, AZoCleantech speaks to Anguil about the decarbonization of battery manufacturing,
and how to make the industry greener from testing to recycling.